诺维克斯:一种新型抗生素类别,对抗多药耐药细菌病原体具有强烈活性――设计,合成和生物评估
Esra Malkawi1,2,3, Anish Parmar1,2, Sanjit Das1,2
1Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology and Therapeutics, William Henry Duncan Building, University of Liverpool, Liverpool L7 8TX, U.K.
Journal of medicinal chemistry
|September 16, 2025
概括
一个新的抗生素类别,Novltex,提供了一种高产率,具有成本效益的解决方案,用于对抗多药耐药细菌. 这种新型化合物对优先病原体表现出强烈的活性,解决了抗生素开发中的关键需求.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 耐多药 (MDR) 细菌需要新型抗生素以高效的合成.
- 诺沃29 (克洛维巴克) 是有前途的,但在产量和合成成本方面存在局限性.
- d-hydroxy-asparagine (d-Hyn5) 是Novo29合成中的一个昂贵的成分.
研究的目的:
- 开发一种具有提高产量和成本效益的新型抗生素类.
- 通过将Leu10-teixobactin宏循环与Novo29 N-terminus尾部融合来设计一种新型抗生素.
- 为了用更容易获得的氨基酸d-Hyn5取代d-Hyn5,threonine.
主要方法:
- 通过结合teixobactin和Novo29结构元素,合成了一种新型抗生素类别Novltex.
- 开发了一种高效的合成路径,其产量为30%,并具有快速合周期.
- 创建并选了一个16个成员的模拟库来识别化合物.
主要成果:
- 诺维克斯合成实现了30%的产量,明显高于Novo29.
- 模拟物12显示强效活性 (MIC 0.12-0.5μg/mL) 针对WHO优先病原体如MRSA和Enterococcus faecium.
- 这种新抗生素保持了原始作用机制 (结合脂质II) 并显示出良好的安全性.
结论:
- 诺维莱克斯代表了下一代抗生素的实用,高产量和成本效益的平台.
- 开发的类似物有效向多药耐药性感染.
- 这种方法为可扩展的抗生素生产提供了一个可行的策略.
相关概念视频
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
Antibiotic Selection
59.4K
Overview
59.4K
Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Antimicrobial Effectiveness
908
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908
Drug Discovery: Overview
11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K


